BAS
IONS icon

Brown Advisory Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Brown Advisory Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$370K – 152
2022
Q1 		$370K Sell
10,000
-3,000
-23% -$98.2K 0.22% 105
2021
Q4 		$394K Sell
13,000
-2,500
-16% -$78.7K 0.17% 122
2021
Q3 		$521K Buy
15,500
+2,000
+15% +$75.4K 0.15% 135
2021
Q2 		$539K Buy
13,500
+8,025
+147% +$314K 0.08% 146
2021
Q1 		$246K Buy
5,475
+300
+6% +$16.7K 0.04% 214
2020
Q4 		$293K Sell
5,175
-250
-5% -$12.5K 0.05% 196
2020
Q3 		$257K Buy
5,425
+625
+13% +$34.7K 0.05% 196
2020
Q2 		$295K Hold
4,800
– – 0.06% 175
2020
Q1 		$247K Hold
4,800
– – 0.06% 191
2019
Q4 		$288K Hold
4,800
– – 0.07% 193
2019
Q3 		$288K Hold
4,800
– – 0.08% 187
2019
Q2 		$308K Sell
4,800
-300
-6% -$21.2K 0.08% 186
2019
Q1 		$411K Sell
5,100
-1,051
-17% -$67.8K 0.1% 185
2018
Q4 		$330K Buy
6,151
+276
+5% +$14.1K 0.06% 246
2018
Q3 		$302K Buy
5,875
+300
+5% +$14.1K 0.05% 297
2018
Q2 		$233K Sell
5,575
-100
-2% -$4.43K 0.04% 331
2018
Q1 		$249K Hold
5,675
– – 0.05% 309
2017
Q4 		$285K Sell
5,675
-900
-14% -$49.4K 0.06% 283
2017
Q3 		$331K Hold
6,575
– – 0.07% 240
2017
Q2 		$335K Sell
6,575
-215
-3% -$10K 0.08% 235
2017
Q1 		$272K Hold
6,790
– – 0.07% 251
2016
Q4 		$324K Sell
6,790
-600
-8% -$23.7K 0.09% 218
2016
Q3 		$271K Buy
+7,390
New +$231K 0.08% 236

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Brown Advisory Securities's IONS Position: Q2 2022 in Review

Brown Advisory Securities sold out of Ionis Pharmaceuticals (IONS) in Q2 2022, closing a stake of 10,000 shares — an estimated $370K sold.

Brown Advisory Securities first reported a position in IONS in Q3 2016 and held it in 23 quarters. The position peaked at $539K in Q2 2021. 349 funds tracked by Wall St. Rank hold IONS as of Q2 2022.

  • Brown Advisory Securities reported no remaining Ionis Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Brown Advisory Securities sold 10,000 Ionis Pharmaceuticals shares in Q2 2022, an estimated $370K.
  • Brown Advisory Securities first reported a position in Ionis Pharmaceuticals in Q3 2016 and held it in 23 quarters.
  • Brown Advisory Securities's Ionis Pharmaceuticals position peaked at $539K in Q2 2021.
  • 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2022.

Based on Brown Advisory Securities's 13F filing for Q2 2022, filed 2 Aug 2022.